Navigation Links
University Health Shreveport Unveils Xenex Germ-Zapping Robot to Enhance Patient Safety
Date:11/21/2013

SHREVEPORT, La., Nov. 21, 2013 /PRNewswire/ -- University Health Shreveport is the first and only acute care hospital in Louisiana to use Xenex Disinfection Services' germ-zapping technology to increase patient safety.

The portable disinfection device uses pulsed xenon to deliver ultraviolet (UV) light that is 25,000 times more powerful than sunlight to destroy deadly bacteria, viruses, fungi and bacterial spores. The device is proven to destroy the most dangerous and hard-to-kill superbugs like Clostridium difficile (C. diff), norovirus, influenza and MRSA (antibiotic-resistant staph bacteria). This technology is used in addition to extensive cleaning services provided by the hospital's Environmental Services team.

"University Health is committed to patient safety. Xenex is a high-level disinfection option that complements the strong disinfection program we already have in place," said Dr. Kevin Sittig, Chief Medical Officer at University Health. "Bacteria that have become smart enough to grow on surfaces like computer keyboards cannot hide from this light. They will be destroyed by this new technology. We have zero tolerance for hospital-acquired infections and this Xenex robot helps us achieve our goal."

One U.S. hospital that uses the Xenex room disinfection system has reported a 53 percent decrease in C. diff infections, according to published data. A "green," mercury-free technology, the Xenex system is the fastest, safest and most effective method for the advanced cleaning of hospital rooms. In just five to 10 minutes, the device can disinfect high-risk patient areas, including operating rooms and equipment, patient rooms and bathrooms. The Xenex unit pulses UV light over high-touch surfaces where germs reside, destroying the deadly pathogens without leaving a chemical residue.

"Xenex devices are proven to destroy the dangerous microorganisms that cause infections. Innovative hospitals like University Health that are focused on patient safety and improving the quality of care of their patients are embracing our room disinfection system because it works," said Dr. Mark Stibich, co-founder and Chief Scientific Officer of Xenex.

About Xenex Disinfection Services
Xenex's patented pulse xenon UV room disinfection system is a pesticidal device used for the advanced environmental cleaning of health care facilities. The Xenex system integrates smoothly into hospital cleaning operations because of its speed and ease of use. The Xenex mission is to eliminate bacteria, viruses and spores in the patient environment that can cause hospital-acquired infections and to become the new standard for disinfection in health care facilities worldwide. For more information, visit www.xenex.com.


'/>"/>
SOURCE University Health Shreveport
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Arizona State University engineers aim to improve performance of technology in extreme environments
2. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
3. Causes of Gulf War Illness are complex and vary by deployment area -- Baylor University study
4. HistoRx Licenses Melanoma Assay from Yale University
5. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
6. Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
7. Research at Rice University leads to nanotube-based device for communication, security, sensing
8. EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics
9. Valkee and University of Oulu Publish the First Clinical Trial on Bright Light Therapy Channeled via ear Canals in Seasonal Depression
10. Oxitec Responds to University of Panamas Forum on Transgenic Mosquitoes
11. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading ... financial results for the fourth quarter and fiscal year of ... Total sales in the fourth quarter of ... 13.6% in USD terms to $77.6 million from $68.3 million ... profit increased by 13.3% to $46.8 million from $41.3 million ...
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that in a published evaluation of multiple immunoassay-based threat detection technologies ... of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to ...
Breaking Biology Technology:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):